{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:28:39Z","timestamp":1788305319003,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.fertnstert.2023.01.046","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T01:57:32Z","timestamp":1675648652000},"page":"540-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Outcomes of clinical in vitro maturation programs for treating infertility in hyper responders: a systematic review"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6529-6912","authenticated-orcid":false,"given":"Lan N.","family":"Vuong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toan D.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuong M.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5019-5924","authenticated-orcid":false,"given":"Michel","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2023.01.046_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.rbmo.2019.04.014","article-title":"Use of cabergoline and post-collection GnRH antagonist administration for prevention of ovarian hyperstimulation syndrome","volume":"39","author":"Shrem","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib6","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib7","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10815-021-02171-8","article-title":"Live births after in\u00a0vitro maturation of oocytes in women who had suffered adnexal torsion and unilateral oophorectomy following conventional ovarian stimulation","volume":"38","author":"Vesztergom","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib9","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib10","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1093\/humrep\/deaa226","article-title":"The freeze-all strategy vs. agonist triggering with low-dose hCG for luteal phase support in IVF\/ICSI for high responders: a randomized controlled trial","volume":"35","author":"Santos-Ribeiro","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib11","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/aogs.13664","article-title":"Do female age and body weight modify the effect of individualized FSH dosing in IVF\/ICSI treatment? A secondary analysis of the OPTIMIST trial","volume":"98","author":"Leijdekkers","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib12","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/dew208","article-title":"The definition of IVM is clear-variations need defining","volume":"31","author":"De Vos","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib13","first-page":"298","article-title":"Practice Committees of the American Society for Reproductive Medicine, Society of Reproductive Biologists and Technologists, Society for Assisted Reproductive Technology. In\u00a0vitro maturation: a committee opinion","volume":"115","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/rep.0.1210051","article-title":"Maturation of human oocytes in\u00a0vitro and their developmental competence","volume":"121","author":"Trounson","year":"2001","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/humrep\/deab243","article-title":"In\u00a0vitro maturation without gonadotropins vs. in\u00a0vitro fertilization with hyperstimulation in women with polycystic ovary syndrome: a non-inferiority randomized controlled trial","volume":"37","author":"Zheng","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10815-013-0143-6","article-title":"A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in\u00a0vitro maturation therapy","volume":"31","author":"Rose","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib17","first-page":"CD008720","article-title":"Human chorionic gonadotrophin priming for fertility treatment with in\u00a0vitro maturation","volume":"11","author":"Reavey","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0015-0282(16)54068-0","article-title":"Pregnancy after in\u00a0vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in\u00a0vitro and their transfer in a donor oocyte program","volume":"55","author":"Cha","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s10815-021-02263-5","article-title":"Perspectives on the development and future of oocyte IVM in clinical practice","volume":"38","author":"De Vos","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.annonc.2020.01.005","article-title":"First birth achieved after fertility preservation using vitrification of in\u00a0vitro matured oocytes in a woman with breast cancer","volume":"31","author":"Grynberg","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib21","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/deu155","article-title":"Human in\u00a0vitro oocyte maturation is not associated with increased imprinting error rates at LIT1, SNRPN, PEG3 and GTL2","volume":"29","author":"Kuhtz","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib22","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/humrep\/dez086","article-title":"Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes vs. controlled ovarian stimulation","volume":"34","author":"Mostinckx","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib23","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/humrep\/dez121","article-title":"DNA methylation and mRNA expression of imprinted genes in blastocysts derived from an improved in\u00a0vitro maturation method for oocytes\u00a0from small antral follicles in polycystic ovary syndrome patients","volume":"34","author":"Saenz-de-Juano","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/humrep\/deu329","article-title":"Chromosome constitution of human embryos generated after in\u00a0vitro maturation including 3-isobutyl-1-methylxanthine in the oocyte collection medium","volume":"30","author":"Spits","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib25","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/humrep\/deaa240","article-title":"In-vitro maturation of oocytes vs. conventional IVF in women with infertility and a high antral follicle count: a randomized non-inferiority controlled trial","volume":"35","author":"Vuong","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/humrep\/dez060","article-title":"The effectiveness and safety of in\u00a0vitro maturation of oocytes vs. in\u00a0vitro fertilization in women with a high antral follicle count","volume":"34","author":"Ho","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib27","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/humrep\/deaa190","article-title":"Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact?","volume":"35","author":"Mackens","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib28","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/humrep\/dev125","article-title":"In\u00a0vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts","volume":"30","author":"Walls","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/humrep\/det034","article-title":"A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count","volume":"28","author":"Guzman","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib30","doi-asserted-by":"crossref","first-page":"hoz034","DOI":"10.1093\/hropen\/hoz034","article-title":"The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment","volume":"2020","author":"Braam","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.rbmo.2020.09.022","article-title":"In-vitro maturation vs. IVF: a cost-effectiveness analysis","volume":"42","author":"Braam","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.rbmo.2020.05.010","article-title":"Mild ovarian stimulation for IVF is the smartest way forward","volume":"41","author":"Nargund","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib33","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib34","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"Lau","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib36","series-title":"Meta-analysis, decision analysis and cost- effectiveness analysis","author":"Pettiti","year":"1999"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib38","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10815-021-02180-7","article-title":"Fresh embryo transfer vs. freeze-only after in\u00a0vitro maturation with a pre-maturation step in women with high antral follicle count: a randomized controlled pilot study","volume":"38","author":"Vuong","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib39","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.fertnstert.2008.04.014","article-title":"Obstetric outcomes following vitrification of in\u00a0vitro and in\u00a0vivo matured oocytes","volume":"91","author":"Chian","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/deu248","article-title":"In\u00a0vitro maturation as an alternative to standard in\u00a0vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes","volume":"30","author":"Walls","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejogrb.2014.05.013","article-title":"In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?","volume":"179","author":"Shavit","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2012.07.001","article-title":"PCOS patients can benefit from in\u00a0vitro maturation (IVM) of oocytes","volume":"165","author":"Shalom-Paz","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2012.04.046","article-title":"In\u00a0vitro maturation or in\u00a0vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles","volume":"98","author":"Gremeau","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10815-018-1138-0","article-title":"Thirteen years' experience in fertility preservation for cancer patients after in\u00a0vitro fertilization and in\u00a0vitro maturation treatments","volume":"35","author":"Creux","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5653\/cerm.2016.43.2.126","article-title":"Application of serum anti-M\u00fcllerian hormone levels in selecting patients with polycystic ovary syndrome for in\u00a0vitro maturation treatment","volume":"43","author":"Seok","year":"2016","journal-title":"Clin Exp Reprod Med"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib46","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.fertnstert.2004.11.044","article-title":"Obstetric outcome of patients with polycystic ovary syndrome treated by in\u00a0vitro maturation and in\u00a0vitro fertilization-embryo transfer","volume":"83","author":"Cha","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib47","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1093\/humrep\/des359","article-title":"Comparison of the obstetric and perinatal outcomes of children conceived from in\u00a0vitro or in\u00a0vivo matured oocytes in in\u00a0vitro maturation treatments with births from conventional ICSI cycles","volume":"27","author":"Fadini","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib48","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/humrep\/deaa200","article-title":"Early pregnancy loss in patients with polycystic ovary syndrome after IVM vs. standard ovarian stimulation for IVF\/ICSI","volume":"35","author":"Mackens","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib49","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.fertnstert.2019.05.034","article-title":"Obstetrical, neonatal, and long-term outcomes of children conceived from in\u00a0vitro matured oocytes","volume":"112","author":"Yu","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/humupd\/dmaa056","article-title":"Maternal and neonatal outcome and children's development after medically assisted reproduction with in-vitro matured oocytes-a systematic review and meta-analysis","volume":"27","author":"Strowitzki","year":"2021","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib51","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000284627.38540.80","article-title":"Obstetric outcomes and congenital abnormalities after in\u00a0vitro maturation, in\u00a0vitro fertilization, and intracytoplasmic sperm injection","volume":"110","author":"Buckett","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib52","first-page":"15","article-title":"Obstetric outcomes and congenital abnormalities in infants conceived with oocytes matured in\u00a0vitro","volume":"6","author":"Chian","year":"2014","journal-title":"Facts Views Vis Obgyn"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib53","article-title":"Growth development of French children born after in\u00a0vitro maturation","volume":"9","author":"Foix-L'H\u00e9lias","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib54","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/humrep\/dex068","article-title":"Two-year development of children conceived by IVM: a prospective controlled single-blinded study","volume":"32","author":"Roesner","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib55","first-page":"hoz043","article-title":"Growth and other health outcomes of 2-year-old singletons born after IVM vs. controlled ovarian stimulation in mothers with polycystic ovary syndrome","volume":"2020","author":"Belva","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib56","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s10815-022-02559-0","article-title":"Development of children born after in\u00a0vitro maturation with a prematuration step vs. natural conception: a prospective cohort study","volume":"39","author":"Nguyen","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib57","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.earlhumdev.2006.01.012","article-title":"Growth and development of children conceived by in-vitro maturation of human oocytes","volume":"82","author":"Shu-Chi","year":"2006","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib58","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/humrep\/dei503","article-title":"Obstetric and perinatal outcome and preliminary results of development of children born after in\u00a0vitro maturation of oocytes","volume":"21","author":"S\u00f6derstr\u00f6m-Anttila","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib59","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/humrep\/deac115","article-title":"Development of children born from IVM vs. IVF: 2-year follow-up of a randomized controlled trial","volume":"37","author":"Vuong","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2020.03.029","article-title":"Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection","volume":"114","author":"Witz","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib61","doi-asserted-by":"crossref","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI(\u2020)","volume":"2020","author":"Bosch","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib62","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.rbmo.2020.11.008","article-title":"How frequent is severe ovarian hyperstimulation syndrome after GnRH agonist triggering in high-risk women? A systematic review and meta-analysis","volume":"42","author":"Ioannidou","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib63","doi-asserted-by":"crossref","first-page":"hoz038","DOI":"10.1093\/hropen\/hoz038","article-title":"ART in Europe, 2015: results generated from European registries by ESHRE","volume":"2020","author":"De Geyter","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.rbmo.2020.06.004","article-title":"Trends in ovarian hyperstimulation syndrome hospitalization rates in the USA: an ongoing concern","volume":"41","author":"Rotshenker-Olshinka","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1472-6483(10)60168-X","article-title":"Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study","volume":"19","author":"Fadini","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib66","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.fertnstert.2008.01.066","article-title":"Selection of patients for natural cycle in\u00a0vitro fertilization combined with in\u00a0vitro maturation of immature oocytes","volume":"91","author":"Lim","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10815-011-9589-6","article-title":"Anti-mullerian hormone as a predictive marker for the selection of women for oocyte in\u00a0vitro maturation treatment","volume":"28","author":"Fadini","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib68","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/humrep\/dex319","article-title":"Individualized vs. standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 2: The predicted hyper responder","volume":"32","author":"Oudshoorn","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.rbmo.2018.05.003","article-title":"Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters","volume":"37","author":"De Vos","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib70","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/humupd\/dms031","article-title":"Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment","volume":"18","author":"Gameiro","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib71","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/REP-15-0606","article-title":"Oocyte maturation and quality: role of cyclic nucleotides","volume":"152","author":"Gilchrist","year":"2016","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib72","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/humrep\/dew020","article-title":"Extending prematuration with cAMP modulators enhances the cumulus contribution to oocyte antioxidant defence and oocyte quality via gap junctions","volume":"31","author":"Li","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib73","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s10815-019-01551-5","article-title":"Biphasic in\u00a0vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles","volume":"36","author":"Sanchez","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2023.01.046_bib74","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/humrep\/dex262","article-title":"An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield","volume":"32","author":"S\u00e1nchez","year":"2017","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028223001279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028223001279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:37:17Z","timestamp":1758011837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028223001279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0015028223001279"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2023.01.046","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of clinical in vitro maturation programs for treating infertility in hyper responders: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2023.01.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92023 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}